Medical therapies with adult stem/progenitor cells (MSCs): A backward journey from dramatic results in vivo to the cellular and molecular explanations

Journal of Cellular Biochemistry

Volumn 113, Issue 5, 2012, Pages 1460-1469

  Prockop, Darwin J ^a   Oh, Joo Youn ^b  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b Seoul National University Hospital   (South Korea)

Author keywords

ADULT STEM PROGENITOR CELL; MESENCHYMAL STEM CELL; MULTIPOTENT MESENCHYMAL STROMAL CELL; STEM CELL

Indexed keywords

ANTIINFLAMMATORY ACTIVITY; ARTICLE; HUMAN; IMMUNOMODULATION; IN VIVO STUDY; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL RESEARCH; TISSUE INJURY;

ADULT STEM CELLS; ANIMALS; APOPTOSIS; HUMANS; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; TRANSLATIONAL MEDICAL RESEARCH; WOUND HEALING;

ANIMALIA;

EID: 84859015846     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24046     Document Type: Article

References (64)

1. Ben-Ami E, Berrih-Aknin S, Miller A,. 2011. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases. Autoimmun Rev 10: 410-415.
2. Bernardo ME, Locatelli F, Fibbe WE,. 2009. Mesenchymal stromal cells. Ann NY Acad Sci 1176: 101-117.
3. Bianco P, Sacchetti B, Riminucci M,. 2011. Osteoprogenitors and the hematopoietic microenvironment. Best Pract Res Clin Haematol 24: 37-47.
4. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, DiMattia G, Sullivan DE, Prockop DJ,. 2009. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 27: 670-681.
5. Caplan AI,. 1991. Mesenchymal stem cells. J Orthop Res 9: 641-650.
6. Chen GY, Nuñez G,. 2010. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 10: 826-837.
7. Choi H, Lee RH, Bazhanov N, Oh JY, Prockop DJ,. 2011. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. Blood 118: 330-338.
8. Crobu F, Latini V, Marongiu MF, Sogos V, Scintu F, Porcu S, Casu C, Badiali M, Sanna A, Manchinu MF, Ristaldi MS,. 2011. Differentiation of single cell derived human mesenchymal stem cells into cells with a neuronal phenotype: RNA and microRNA expression profile. Mol Biol Rep Epub ahead of print.
9. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E,. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. (Pubitemid 44269669)
10. Eigenbrod T, Park JH, Harder J, Iwakura Y, Nuñez G,. 2008. Cutting edge: Critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1 alpha released from dying cells. J Immunol 181: 8194-8198.
11. Ellard JP, McCudden CR, Tanega C, James KA, Ratkovic S, Staples JF, Wagner GF,. 2007. The respiratory effects of stanniocalcin-1 (STC-1) on intact mitochondria and cells: STC-1 uncouples oxidative phosphorylation and its actions are modulated by nucleotide triphosphates. Mol Cell Endocrinol 264: 90-101. (Pubitemid 46097304)
12. Fang L, Gao XM, Moore XL, Kiriazis H, Su Y, Ming Z, Lim YL, Dart AM, Du XJ,. 2007. Differences in inflammation, MMP activation and collagen damage account for gender difference in murine cardiac rupture following myocardial infarction. J Mol Cell Cardiol 43: 535-544. (Pubitemid 47615041)
13. Friedenstein AJ, Gorskaja JF, Kulagina NN,. 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4: 267-274.
14. Gabay C, Lamacchia C, Palmer G,. 2010. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6: 232-241.
15. Gordon S, Martinez FO,. 2010. Alternative activation of macrophages: Mechanism and functions. Immunity 32: 593-604.
16. Gregory CA, Ylostalo J, Prockop DJ,. 2005. Adult bone marrow stem/progenitor cells (MSCs) are preconditioned by microenvironmental "niches" in culture: A two-stage hypothesis for regulation of MSC fate. Sci STKE 294: pe37.
17. Gregory LA, Ricart RA, Patel SA, Lim PK, Rameshwar P,. 2011. MicroRNAs, Gap junctional intercellular communication and mesenchymal stem cells in breast cancer metastasis. Curr Cancer Ther Rev 7: 176-183.
18. Guo L, Zhao RC, Wu Y,. 2011. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Exp Hematol 39: 608-616.
19. Izcue A, Coombes JL, Powrie F,. 2009. Regulatory lymphocytes and intestinal inflammation. Annu Rev Immunol 27: 313-338.
20. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA,. 2007. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563. (Pubitemid 47525152)
21. Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC,. 2009. Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27: 2614-2623.
22. Kim J, Hematti P,. 2009. Mesenchymal stem cell-educated macrophages: A novel type of alternatively activated macrophages. Exp Hematol 37: 1445-1453.
23. Koga H, Muneta T, Nagase T, Nimura A, Ju YJ, Mochizuki T, Sekiya I,. 2008. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: Suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res 33: 207-215.
24. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Gottesfeld J, Izpisua Belmonte JC, Murry C, Keirstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, Loring JF,. 2011. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8: 106-118.
25. Le Blanc K, Rasmusson I, Sundberg B, Götherström C, Hassan M, Uzunel M, Ringdén O,. 2004. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441. (Pubitemid 38586721)
26. Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, Semprun-Prieto L, Delafontaine P, Prockop DJ,. 2009. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5: 54-63.
27. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzón IM, Nepomnaschy I, Costa H, Cañones C, Raiden S, Vermeulen M, Geffner JR,. 2010. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5: e9252.
28. Mahoney DJ, Mikecz K, Ali T, Mabilleau G, Benayahu D, Plaas A, Milner CM, Day AJ, Sabokbar A,. 2008. TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation. J Biol Chem 283: 25952-25962.
29. Medzhitov R,. 2010. Innate immunity: Quo vadis? Nat Immunol 11: 551-553.
30. Mei SH, Haitsma JJ, Dos Santos CC, Deng Y, Lai PF, Slutsky AS, Liles WC, Stewart DJ,. 2010. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 182: 1047-1057.
31. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS,. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
32. Milner CM, Tongsoongnoen W, Rugg MS, Day AJ,. 2007. The molecular basis of inter-alpha-inhibitor heavy chain transfer on to hyaluronan. Biochem Soc Trans 35: 672-676. (Pubitemid 47310338)
33. Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ,. 2005. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci USA 102: 18171-18176. (Pubitemid 41798520)
34. Nathan C, Ding A,. 2010. Nonresolving inflammation. Cell 140: 871-882.
35. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E,. 2009. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15: 42-49.
36. Oh JY, Roddy GW, Choi H, Lee RH, Ylöstalo JH, Rosa RH Jr, Prockop DJ,. 2010. Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury. Proc Natl Acad Sci USA 107: 16875-16880.
37. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG,. 2003. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 100: 8407-8411. (Pubitemid 36842558)
38. Ortiz LA, Dutreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG,. 2007. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci USA 104: 11002-11007. (Pubitemid 47175216)
39. Owen M, Friedenstein AJ,. 1988. Stromal stem cells: Marrow-derived osteogenic precursors. Ciba Found Symp 136: 42-60.
40. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147. (Pubitemid 29282067)
41. Pochampally RR, Smith JR, Ylostalo J, Prockop DJ,. 2004. Serum deprivation of human marrow stromal cells (hMSCs) selects for a subpopulation of early progenitor cells with enhanced expression of OCT-4 and other embryonic genes. Blood 103: 1647-1652. (Pubitemid 38268955)
42. Prockop DJ,. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74. (Pubitemid 27161245)
43. Prockop DJ, Brenner M, Fibbe WE, Horwitz E, Le Blanc K, Phinney DG, Simmons PJ, Sensebe L, Keating A,. 2010a. Defining the risks of mesenchymal stromal cell therapy. Cytotherapy 12: 576-578.
44. Prockop DJ, Kota DJ, Bazhanov N, Reger RL,. 2010b. Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs). J Cell Mol Med 14: 2190-2199.
45. Prockop DJ, Oh JY,. 2011. Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation. Mol Ther Epub ahead of print.
46. Rebbeck CA, Leroi AM, Burt A,. 2011. Mitochondrial capture by a transmissible cancer. Science 331: 303.
47. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y,. 2008. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150. (Pubitemid 351181031)
48. Rock KL, Latz E, Ontiveros F, Kono H,. 2010. The sterile inflammatory response. Annu Rev Immunol 28: 321-342.
49. Roddy GW, Oh JY, Lee RH, Bartosh TJ, Ylostalo J, Coble K, Rosa RH Jr, Prockop DJ,. 2011. Action at a distance: Systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6. Stem Cells 29: 1572-1579.
50. Romieu-Mourez R, François M, Boivin MN, Bouchentouf M, Spaner DE, Galipeau J,. 2009. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 182: 7963-7973.
51. Rubin H,. 2001. Multistage carcinogenesis in cell culture. Dev Biol (Basel) 106: 61-66.
52. Serhan CN, Chiang N, Van Dyke TE,. 2008. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8: 349-361. (Pubitemid 351595216)
53. So A, De Smedt T, Revaz S, Tschopp J,. 2007. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res Ther 9: R28.
54. Spees JL, Olson SD, Whitney MJ, Prockop DJ,. 2006. Mitochondrial transfer between cells can rescue aerobic respiration. Proc Natl Acad Sci USA 103: 1283-1288. (Pubitemid 43191157)
55. Tolar J, Nauta AJ, Osborn MJ, Panoskaltsis Mortari A, McElmurry RT, Bell S, Xia L, Zhou N, Riddle M, Schroeder TM, Westendorf JJ, McIvor RS, Hogendoorn PC, Szuhai K, Oseth L, Hirsch B, Yant SR, Kay MA, Peister A, Prockop DJ, Fibbe WE, Blazar BR,. 2007. Sarcoma derived from cultured mesenchymal stem cells. Stem Cells 25: 371-379. (Pubitemid 46232791)
56. Uccelli A, Moretta L, Pistoia V,. 2008. Mesenchymal stem cells in health and disease. Nat Rev Immunol 8: 726-736.
57. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, Tanimura Y, Tsuchiyama K, Kikuchi T, Goda M, Nakahata T, Fujiyoshi Y, Dezawa M,. 2011. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci USA 108: 9875-9880.
58. Wan YY,. 2010. Regulatory T cells: Immune suppression and beyond. Cell Mol Immunol 7: 204-210.
59. Wang Y, Huang L, Abdelrahim M, Cai Q, Truong A, Bick R, Poindexter B, Sheikh-Hamad D,. 2009. Stanniocalcin-1 suppresses superoxide generation in macrophages through induction of mitochondrial UCP2. J Leukoc Biol 86: 981-988.
60. Wisniewski HG, Vilcek J,. 2004. Cytokine-induced gene expression at the crossroads of innate immunity, inflammation and fertility: TSG-6 and PTX3/TSG-14. Cytokine Growth Factor Rev 15: 129-146. (Pubitemid 38521249)
61. Yagi H, Soto-Gutierrez A, Navarro-Alvarez N, Nahmias Y, Goldwasser Y, Kitagawa Y, Tilles AW, Tompkins RG, Parekkadan B, Yarmush ML,. 2010. Reactive bone marrow stromal cells attenuate systemic inflammation via sTNFR1. Mol Ther 18: 1857-1864.
62. Ylöstalo J, Bazhanov N, Prockop DJ,. 2008. Reversible commitment to differentiation by human multipotent stromal cells in single-cell-derived colonies. Exp Hematol 36: 1390-1402.
63. Zhang JF, Fu WM, He ML, Xie WD, Lv Q, Wan G, Li G, Wang H, Lu G, Hu X, Jiang S, Li JN, Lin MC, Zhang YO, Kung H,. 2011. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol Epub ahead of print.
64. Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, Nguyen AL, Kwon CW, Le AD,. 2010. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28: 1856-1868.